The recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined jointly after a clinical evaluation and discussion between the patient and their care provider. The app should not be used by patients to guide their own care.
The information and recommendations in this app are derived from ACC/AHA’s 2013 Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. It was developed as part of the American College of Cardiology’s “LDL: Address the Risk” Initiative and further refined and vetted by physicians, physician assistants, nurse practitioners, pharmacists, and other relevant specialties; and through user testing in care settings with patients.
Financial support for the app was generously provided by Amgen. All content was developed independently with no sponsor involvement.